ABI s New 3730 Gets Thumbs-Up From Early-Access Labs (So Far). But Will it Fly in a Flat Market | GenomeWeb

SAN FRANCISCO, Aug. 12 - Applied Biosystems' next-generation sequencer, scheduled for commercial introduction on Wednesday, is in the hands of early-access partners. So far they're impressed. The next challenge for ABI is to sell the tools in a receding sequencing market.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.